丹麦 1996-2016 年 1 型和 2 型糖尿病的终身风险和损失年数。

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016.

机构信息

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Steno Diabetes Center Copenhagen, Gentofte, Denmark

出版信息

BMJ Open Diabetes Res Care. 2021 Mar;9(1). doi: 10.1136/bmjdrc-2019-001065.

Abstract

INTRODUCTION

Lifetime risk and lifetime lost to diabetes are measures of current diabetes burden in a population. We aimed at quantifying these measures in the Danish population.

RESEARCH DESIGN AND METHODS

We modeled incidence and mortality of type 1 diabetes (T1D) and type 2 diabetes (T2D) and non-diabetes mortality based on complete follow-up of the entire population of Denmark in 1996-2016. A multistate model with these transition rates was used to assess the lifetime risk of diabetes, as well as the difference in expected lifetime between persons with type 1 and T2D and persons without.

RESULTS

In 2016, the lifetime risk of T1D was 1.1% and that for T2D 24%, the latter a 50% increase from 1996. For 50-year-old persons, the lifetime lost was 6.6 years for T1D and 4.8 years for T2D. These figures have been declining over the study period.At 2016, the total foreseeable lives lost in Denmark among patients with T1D were 182 000 years, and those among patients with T2D were 766 000 years, corresponding to 6.6 and 3.0 years per person, respectively.

CONCLUSION

At the individual level, improvements in the disease burden for both T1D and T2D have occurred. At the population level, the increasing number of patients with T2D has contributed to a large increase in the total loss of lifetime.

摘要

简介

终生风险和因糖尿病而损失的寿命是衡量当前人群中糖尿病负担的指标。我们旨在量化丹麦人群中的这些指标。

研究设计和方法

我们根据丹麦 1996 年至 2016 年期间的全民完整随访数据,建立了 1 型糖尿病(T1D)和 2 型糖尿病(T2D)的发病和死亡模型以及非糖尿病死亡率模型。使用具有这些转移率的多状态模型来评估糖尿病的终生风险,以及 1 型和 T2D 患者与无糖尿病患者之间预期寿命的差异。

结果

2016 年,T1D 的终生风险为 1.1%,T2D 的终生风险为 24%,后者比 1996 年增加了 50%。对于 50 岁的人,T1D 的终生损失为 6.6 年,T2D 的终生损失为 4.8 年。这些数字在研究期间一直在下降。2016 年,丹麦 T1D 患者预计总寿命损失为 182000 年,T2D 患者预计总寿命损失为 766000 年,分别相当于每人损失 6.6 年和 3.0 年。

结论

在个体层面,T1D 和 T2D 的疾病负担都有所改善。在人群层面,T2D 患者数量的增加导致总寿命损失大幅增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a662/7929801/d29628f3ec6b/bmjdrc-2019-001065f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索